Close Menu

NEW YORK (360Dx) – Quidel said today that it has inked an agreement to acquire Alere's Triage B-type naturietic peptide assay business and its Triage MeterPro cardiovascular and toxicology assets for $400 million and $40 million in contingent consideration.

The deal includes Triage's facility and associated real estate in San Diego.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.